[1] |
Morton L M, Turner J J, Cerhan J R, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).[J]. Blood, 2007, 110(2):695-708.
|
[2] |
Anderson K C, Alsina M, Bensinger W, et al. Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.[J]. Journal of NCCN, 2012, 10(10):1211.
|
[3] |
祁 健,陈 晨,王荣梅.利妥昔单抗引起肝功能损害1例[J].中国医院药学杂志,2017,(9):892-893.
|
[4] |
陈 永,高永艳,李 艳, 等.利妥昔单抗致不良反应325例文献分析[J].广东药学院学报,2010,26(2):179-181.
|
[5] |
Todd D J, Helfgott S M. Serum sickness following treatment with rituximab[J]. Journal of Rheumatology, 2007, 34(2):430-433.
|
[6] |
Heresi G A, Farver C F, Stoller J K. Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature[J]. Respiration, 2007, 76(4):449-453.
|
[7] |
赵 敏,张秀红.利妥昔单抗引起过敏反应2例[J].药物不良反应杂志,2010,12(1):58-59.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(8): 713-715. |
|
|
|